Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2021-01-28 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
2020年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a "2020年度业绩预告" which translates to "2020 Annual Performance Forecast" or earnings guidance. It provides estimated financial results for the full year 2020, including net profit attributable to shareholders, earnings per share, and explanations for performance changes. It explicitly states that the data is preliminary and unaudited, with final audited results to be disclosed in the 2020 Annual Report. The document is relatively short (1956 characters) and serves as a performance forecast rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of periodic financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it an announcement of report publication (RPA). Therefore, the correct classification is Earnings Release (ER). FY 2020
2021-01-28 Chinese
关于变更证券简称的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's securities short name and related details. It includes information about the new Chinese and English securities abbreviations, the effective date of the change, and the reasons behind the change due to a major asset restructuring. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The document is a formal announcement about a change in the company's securities abbreviation, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2021-01-07 Chinese
联合资信评估股份有限公司关于公司完成重大资产重组并更改公司名称和经营范围的公告
Regulatory Filings
2021-01-07 Chinese
2020年第四季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of Zhejiang Huazhong Pharmaceutical Co., Ltd. It details the bond issuance, conversion price adjustments, and the changes in shareholding due to bond conversions during the fourth quarter of 2020. The document includes specific bond codes, stock codes, conversion prices, dates, and shareholding changes. It is a formal announcement of bond conversion activity and share capital changes, not a full financial report or earnings release. The document length is relatively short (2425 characters) and it is a regulatory announcement about bond conversion and shareholding changes, fitting the category of Capital/Financing Update (CAP).
2021-01-04 Chinese
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the completion of industrial and commercial registration changes and the issuance of a new business license. It details changes in company name, business scope, registered capital, and other corporate information following a major asset acquisition. The document is a formal disclosure of corporate changes and does not contain financial statements, audit information, or detailed financial performance data. It is not a report itself but an announcement of corporate changes and regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-12-30 Chinese
关于向全资子公司划转资产的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the internal transfer of assets to its wholly-owned subsidiary. It details the asset transfer, the involved parties, the impact on the company, and related procedural information. The document explicitly states that this is an internal asset transfer and not a major asset restructuring requiring shareholder approval. There are no financial statements or detailed financial performance data included, and the document is relatively short (2881 characters). It is a regulatory announcement about a corporate action (asset transfer) rather than a full financial report or audit. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-12-28 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.